Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency

Gene

Volumn 542, Issue 2, 2014, Pages 129-133

  Al Daghri, Nasser M ^a,b   Al Attas, Omar S ^a,b   Alkharfy, Khalid M ^a,b,c   Khan, Nasiruddin ^b   Mohammed, Abdul Khader ^a,b   Vinodson, Benjamin ^a,b   Ansari, Mohammed Ghouse Ahmed ^b   Alenad, Amal ^d   Alokail, Majed S ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

25 Hydroxyvitamin D; Cardiovascular diseases; Haplotype; Obesity; Polymorphism

Indexed keywords

25-HYDROXYVITAMIN D; CARDIOVASCULAR DISEASES; HAPLOTYPE; OBESITY; POLYMORPHISM;

ADULT; ARABS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; SAUDI ARABIA; VITAMIN D DEFICIENCY;

EID: 84898813474     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.044     Document Type: Article

References (36)

1. Al-Daghri N.M., Al-Attas O., Alokail M.S., Alkharfy K.M., Draz H.M., Agliardi C., Mohammed A.K., Guerini F.R., Clerici M. Vitamin D receptor gene polymorphisms and HLA DRB1*04 cosegregation in Saudi type 2 diabetes patients. Journal of Immunology 2012, 188:1325-1332.
2. Al-Daghri N.M., Alkharfy K.M., Al-Saleh Y., Al-Attas O.S., Alokail M.S., Al-Othman A., Moharram O., El-Kholie E., Sabico S., Kumar S., Chrousos G.P. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 2012, 61:661-666.
3. Alkharfy K.M., Al-Daghri N.M., Al-Attas O.S., Alokail M.S., Mohammed A.K., Vinodson B., Clerici M., Kazmi U., Hussain T., Draz H.M. Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population. Endocrine Journal 2012, 59:253-263.
4. Bhanushali A.A., Lajpal N., Kulkarni S.S., Chavan S.S., Bagadi S.S., Das B.R. Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels. Indian Journal of Human Genetics 2009, 15:108-113.
5. Bid H.K., Konwar R., Aggarwal C.G., Gautam S., Saxena M., Nayak V.L., Banerjee M. Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study. Indian Journal of Medical Sciences 2009, 63:187-194.
6. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. The American Journal of Clinical Nutrition 2006, 84:18-28.
7. Christakos S., Raval-Pandya M., Wernyj R.P., Yang W. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. The Biochemical Journal 1996, 316(Pt 2):361-371.
8. d'Alesio A., Garabedian M., Sabatier J.P., Guaydier-Souquieres G., Marcelli C., Lemacon A., Walrant-Debray O., Jehan F. Two single-nucleotide polymorphisms in the human vitamin D receptor promoter change protein-DNA complex formation and are associated with height and vitamin D status in adolescent girls. Human Molecular Genetics 2005, 14:3539-3548.
9. Dundar U., Solak M., Kavuncu V., Ozdemir M., Cakir T., Yildiz H., Evcik D. Evidence of association of vitamin D receptor Apa I gene polymorphism with bone mineral density in postmenopausal women with osteoporosis. Clinical Rheumatology 2009, 28:1187-1191.
10. Filus A., Trzmiel A., Kuliczkowska-Plaksej J., Tworowska U., Jedrzejuk D., Milewicz A., Medras M. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. The Aging Male 2008, 11:134-139.
11. Ford E.S., Ajani U.A., McGuire L.C., Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228-1230.
12. Grundberg E., Brandstrom H., Ribom E.L., Ljunggren O., Mallmin H., Kindmark A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. European Journal of Endocrinology 2004, 150:323-328.
13. Howard G., Nguyen T., Morrison N., Watanabe T., Sambrook P., Eisman J., Kelly P.J. Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. The Journal of Clinical Endocrinology and Metabolism 1995, 80:2800-2805.
14. Lee S., Clark S.A., Gill R.K., Christakos S. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994, 134:1602-1610.
15. Lips P. Vitamin D physiology. Progress in Biophysics and Molecular Biology 2006, 92:4-8.
16. Malecki M.T., Frey J., Moczulski D., Klupa T., Kozek E., Sieradzki J. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Experimental and Clinical Endocrinology and Diabetes 2003, 111:505-509.
17. McDermott M.F., Ramachandran A., Ogunkolade B.W., Aganna E., Curtis D., Boucher B.J., Snehalatha C., Hitman G.A. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997, 40:971-975.
18. Neyestani T.R., Djazayery A., Shab-Bidar S., Eshraghian M.R., Kalayi A., Shariatzadeh N., Khalaji N., Zahedirad M., Gharavi A., Houshiarrad A., Chamari M., Asadzadeh S. Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 2013, 36:550-556.
19. Nosratabadi R., Arababadi M.K., Salehabad V.A., Shamsizadeh A., Mahmoodi M., Sayadi A.R., Kennedy D. Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type-2 diabetes. International Journal of Immunogenetics 2010, 37:493-497.
20. Ogunkolade B.W., Boucher B.J., Prahl J.M., Bustin S.A., Burrin J.M., Noonan K., North B.V., Mannan N., McDermott M.F., DeLuca H.F., Hitman G.A. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51:2294-2300.
21. Oh J.Y., Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002, 51:356-359.
22. Pani M.A., Knapp M., Donner H., Braun J., Baur M.P., Usadel K.H., Badenhoop K. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000, 49:504-507.
23. Panierakis C., Goulielmos G., Mamoulakis D., Petraki E., Papavasiliou E., Galanakis E. Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clinical Immunology 2009, 133:276-281.
24. Pike J.W. Vitamin D3 receptors: structure and function in transcription. Annual Review of Nutrition 1991, 11:189-216.
25. Pittas A.G., Harris S.S., Stark P.C., Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007, 30:980-986.
26. Reis A.F., Hauache O.M., Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes & Metabolism 2005, 31:318-325.
27. Shi H., Norman A.W., Okamura W.H., Sen A., Zemel M.B. 1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB Journal 2001, 15:2751-2753.
28. Smolders J., Damoiseaux J., Menheere P., Tervaert J.W., Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. Journal of Neuroimmunology 2009, 207:117-121.
29. Speer G., Cseh K., Winkler G., Takacs I., Barna I., Nagy Z., Lakatos P. Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers. European Journal of Cancer 2001, 37:1463-1468.
30. Speer G., Cseh K., Winkler G., Vargha P., Braun E., Takacs I., Lakatos P. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. European Journal of Endocrinology 2001, 144:385-389.
31. Tworowska-Bardzinska U., Lwow F., Kubicka E., Laczmanski L., Jedzrzejuk D., Dunajska K., Milewicz A. The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecological Endocrinology 2008, 24:514-518.
32. Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004, 338:143-156.
33. Uitterlinden A.G., Fang Y., van Meurs J.B., van Leeuwen H., Pols H.A. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. The Journal of Steroid Biochemistry and Molecular Biology 2004, 89-90:187-193.
34. Valdivielso J.M., Fernandez E. Vitamin D receptor polymorphisms and diseases. Clinica Chimica Acta 2006, 371:1-12.
35. Velayoudom-Cephise F.L., Larifla L., Donnet J.P., Maimaitiming S., Deloumeaux J., Blanchet A., Massart C., Munoz-Bellili N., Merle S., Chout R., Bonnet F., Foucan L. Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes & Metabolism 2011, 37:540-545.
36. Ye W.Z., Reis A.F., Dubois-Laforgue D., Bellanne-Chantelot C., Timsit J., Velho G. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. European Journal of Endocrinology 2001, 145:181-186.